Cardiac and multiorgan transplantation for end-stage congenital heart disease

Mayo Clinic Proceedings

Volumn 89, Issue 4, 2014, Pages 478-483

  Robinson, Jeffrey A ^a   Driscoll, David J ^a   O'Leary, Patrick W ^a   Burkhart, Harold M ^a   Dearani, Joseph A ^a   Daly, Richard C ^a   Edwards, Brooks S ^a   Dahl, Sonja H ^a   Johnson, Jonathan N ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; CORONARY ARTERY DISEASE; FEMALE; GRAFT SURVIVAL; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LUNG RESISTANCE; MALE; MORTALITY; NEOPLASM; PRESCHOOL CHILD; RETRANSPLANTATION; SCHOOL CHILD; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; UNITED STATES;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CONFIDENCE INTERVALS; CRITICAL ILLNESS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HEART DEFECTS, CONGENITAL; HEART FAILURE; HEART TRANSPLANTATION; HUMANS; INFANT; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MINNESOTA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84898664201     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2013.11.019     Document Type: Article

References (10)

1. Kirk R, Dipchand AI, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: fifteenth pediatric heart transplantation reporte2012. J Heart Lung Transplant. 2012;31(10):1065-1072.
2. Seddio F, Gorislavets N, Iacovoni A, et al. Is heart transplantation for complex congenital heart disease a good option? A 25-year single centre experience. Eur J Cardiothorac Surg. 2013; 43(3):605-611; discussion 611.
3. Voeller RK, Epstein DJ, Guthrie TJ, et al. Trends in the indications and survival in pediatric heart transplants: a 24-year single-center experience in 307 patients. Ann Thorac Surg. 2012;94(3):807-815; discussion 815e816.
4. Karamlou T, Hirsch J, Welke K, et al. A United Network for Organ Sharing analysis of heart transplantation in adults with congenital heart disease: outcomes and factors associated with mortality and retransplantation. J Thorac Cardiovasc Surg. 2010;140(1):161-168.
5. Speziali G, Driscoll DJ, Danielson GK, et al. Cardiac transplantation for end-stage congenital heart defects: the Mayo Clinic experience. Mayo Cardiothoracic Transplant Team. Mayo Clin Proc. 1998;73(10):923-928.
6. Gupta V, Tonelli AR, Krasuski RA. Congenital heart disease and pulmonary hypertension. Heart Fail Clin. 2012;8(3): 427-445.
7. Asrani SK, Asrani NS, Freese DK, et al. Congenital heart disease and the liver. Hepatology. 2012;56(3):1160-1169.
8. Siân Pincott E, Burch M. Indications for heart transplantation in congenital heart disease. Curr Cardiol Rev. 2011; 7(2):51-58.
9. Luo JM, Chou NK, Chen YS, et al. Heart retransplantation for pediatric primary allograft failure. Transplant Proc. 2012;44(4): 913-914.
10. Topilsky Y, Hasin T, Raichlin E, et al. Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation. Circulation. 2012;125(5):708-720.